Main Blog


CAPTURA project kicks off in Seoul, South Korea

  May 27, 2019, SEOUL, South Korea – Today marks the official kick-off meeting of the CAPTURA (‘Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia’) project, an international consortium led by IVI. This 2-day workshop brings together partners including […]

KRIBB scientist Dr. Doo-Jin Kim shares his research findings in influenza vaccines at IVI Seminar

Dr. Doo-Jin Kim, Senior Researcher, Infectious Disease Research Center at the Korea Research Institute of Bioscience & Biotechnology (KRIBB)   Dr. Doo-Jin Kim, Ph.D., Senior Researcher from the Infectious Disease Research Center of the Korea Research Institute of Bioscience & Biotechnology, delivered a lecture entitled: […]

Global push to find vaccine against devastating bug growing

  The Australian Broadcasting Corporation (ABC) carried a story on the new global push to develop the world’s first vaccine against Strep A in the wake of Wellcome Trust’s US$2.25 million grant to IVI and the Murdoch Children’s Research Institute. – Ed.   For most […]

IVI partners with QuadMedicine to develop microneedle-based vaccines

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]